[1]
M. Aydin, “Effectiveness and safety of orally administered silymarin (milk thistle) for pegylated interferon unresponsive chronic delta hepatitis patients: Silymarin treatment for pegylated interferon unresponsive chronic delta hepatitis”, Med Sci Discov, vol. 8, no. 7, pp. 428–431, Jul. 2021.